NANCY JONES: Open Payments
NPI 1184003436 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,325 in 115 payments from 32 companies in 2025. Trend: 2023 $987 · 2024 $2,392 · 2025 $2,325
Food & beverage: $2,325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $307 |
| PFIZER INC. | 12 | $220 |
| AstraZeneca Pharmaceuticals LP | 4 | $206 |
| Amgen Inc. | 11 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $141 |
| Vanda Pharmaceuticals Inc. | 5 | $123 |
| Novo Nordisk Inc | 5 | $120 |
| Astellas Pharma US Inc | 4 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
| Exact Sciences Corporation | 5 | $101 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, HETLIOZ, Veozah, JARDIANCE, Cologuard Collection Kit, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
